azp2006
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 9, 2019 (NCT04008355)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- ProsaposinSTABILISER
PSAP stabiliser
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)CN(CCCN1CCN(CCCNC2=NC3=C(N2)C=CC=C3)CC1)CC(C)C- Mol. weight
- 428.6571 g/mol
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSTR9YQ07ELN ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04008355 | Phase 2 | Aug 9, 2019 | AlzProtect SAS |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AlzProtect SAS | For profit | 1 | 1 | 1 | 2019 |
1 organizations
Page 1 / 1